Silver Patents (Class 424/618)
  • Publication number: 20140044801
    Abstract: The sterilizing and deodorizing agents target bacteria, odors, toxic substances, etc. and are made from silver as metal particles and titanium dioxide as ceramic particles by (1) thermal bonding or (2) pressure bonding or (3) thermal/pressure bonding and mixing the resultant with hydroxyapatite as an adsorptive material. The agent can be mixed with ink, bonding agents and paints and applied to a variety of substrates.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 13, 2014
    Inventors: Tsukasa Sakurada, Charles P. Gerba
  • Patent number: 8647647
    Abstract: A topical formulation for application to exposed body tissue, the formulation comprising a silver(II) oxide and zinc oxide, intimately dispersed within a carrier medium.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: February 11, 2014
    Assignee: Aidance Skincare and Topical Solutions, LLC
    Inventor: Perry Antelman
  • Patent number: 8647652
    Abstract: Methods for preparing silver colloids and silica-coated silver colloids are disclosed. The silver colloids may be prepared by heating a silver-containing solution, combining the heated silver-containing solution with an acid solution, and cooling the combined solutions to form a silver colloid containing silver particles. The silver particles in the silver colloid can further be coated with silica. A method for preparing antimicrobial coatings is also disclosed.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: February 11, 2014
    Assignee: Guardian Industries Corp.
    Inventor: Pramod K Sharma
  • Publication number: 20140037742
    Abstract: By combining the anti-bacterial effects of silver sulfadiazine and silver nanoparticles with the absorption and slow-release capabilities of alginate, a product was created that can be used to heal and protect deep wounds. These microparticles can have a greater surface area to volume ratio. This, in turn, can permit the particles to have a larger area of exposure to bacterial colonies, thereby increasing antimicrobial activity. Additionally, engineered microparticles also may benefit from the ability to conform to the shape of the wound.
    Type: Application
    Filed: July 30, 2013
    Publication date: February 6, 2014
    Inventor: Melissa Fagan
  • Publication number: 20140027358
    Abstract: A system for dispensing water treatment compositions into a pool, spa, or other body of water is disclosed, which system provides a visible cue that the water treatment is properly dispersing and also provides a visible cue when the desired amount of water treatment has been dispensed. The system comprises a dispenser and the water treatment composition contained within the body of the dispenser, which dispenser and which system provides a readily visual cue that when the water treatment dose has been fully, or in some cases mostly or partially dispersed. For example, the dispenser sinks when fully dosed and resurfaces when empty, and in particular embodiments the water treatment comprises a means for generating visible gas bubbles and/or producing a color stream as the treatment dissolves.
    Type: Application
    Filed: April 1, 2013
    Publication date: January 30, 2014
    Applicant: CHEMTURA CORPORATION
    Inventors: CurtIS Sayre, Zach Hansen, David Rouse, Anna Florine McLeroy
  • Patent number: 8637072
    Abstract: The present invention relates to wound dressings, in particular to an antibacterial wound dressing based on silvered gel-forming fabric and to a process for the manufacture of such a wound dressing.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: January 28, 2014
    Assignee: Convatec Technologies, Inc.
    Inventors: David Kershaw, Barry DeBoorder, Stephen John Law
  • Patent number: 8637088
    Abstract: An antimicrobial composition contains a soluble silver salt and an alkanolamine or aminoalcohol. The composition may additionally contain an amino acid or amino acid salt and surfactant. The composition has additional stability and activity compared to prior art silver complexes.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: January 28, 2014
    Assignee: The Clorox Company
    Inventors: David R. Scheuing, Erika Szekeres, Steven Bromberg
  • Patent number: 8637071
    Abstract: The present invention provides a method for preparing a medical device, preferably a contact lens, having an antimicrobial metal-containing LbL coating on a medical device, wherein the antimicrobial metal-containing LbL coating comprises at least one layer of a negatively charged polyionic material having —COOAg groups and/or silver nanoparticles formed by reducing Ag+ ions associated with the —COO? groups of the negatively charged polyionic material. In addition, the present invention provides a medical device prepared according to a method of the invention.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: January 28, 2014
    Assignee: Novartis AG
    Inventors: Michael F. Rubner, Sung Yun Yang, Yongxing Qiu, Lynn Cook Winterton, John Martin Lally
  • Patent number: 8637087
    Abstract: The present invention relates to non-psychoactive derivatives of tetrahydrocannabinol, which are useful in treating interstitial cystitis and relieving symptoms thereof. The invention uses (6aR,10aR)-?8-tetrahydrocannabinol-11-oic acids (hereinafter referred to as (6aR,10aR)-?8-THC-11-oic acid), as well as pharmaceutical compositions containing the (6aR,10aR)-?8-THC-11-oic acids, for treatment of interstitial cystitis in a mammal. The invention further covers methods of formulating and administering the compounds and pharmaceutical compositions as therapeutic agents in the treatment of interstitial cystitis, with particularly preferred administration routes being oral and via intravesicular instillation.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: January 28, 2014
    Assignee: JB Therapeutics Inc.
    Inventors: Bobby W. Sandage, Jr., Glenn L. Cooper
  • Publication number: 20140017335
    Abstract: Acrylic materials with antimicrobial activity are tumble blended, melted and extruded through an extruder. The resulting polymer compounds include an acrylic resin, such as methylmethacrylate polymers, copolymers and multipolymers, and blends thereof, silver-containing antimicrobial additives; and optional additives such as impact modifiers, flow promoters, stabilizers and coloring agents. The properties of the acrylic materials, especially the antimicrobial performance, are strongly dependent on the manufacturing process conditions, including feed resins pre-drying, residual moisture content, screw speed and melt temperature. The materials composition and manufacturing procedures are equally significant.
    Type: Application
    Filed: February 7, 2012
    Publication date: January 16, 2014
    Applicant: EVONIK RÖHM GmbH
    Inventors: Dimo K. Dimov, Lawrence N. Gabriel, Florian Lyon, Christopher R. Spain, Peter D. Colburn, Craig T. Schmidter, Zhen Zhu
  • Publication number: 20140010856
    Abstract: Various embodiments of surface-modified devices, components, and associated methods of manufacturing are described herein. In one embodiment, an implantable device suitable for being implanted in a patient includes an implantable material having a utile shape and a surface and a modification material deposited on at least a portion of the surface of the implantable material. The modification material has a release rate in an implantation environment in the patient. The modification material at the release rate is effective as bactericidal without being cytotoxic to the patient.
    Type: Application
    Filed: March 26, 2012
    Publication date: January 9, 2014
    Applicant: WASHINGTON STATE UNIVERSITY
    Inventors: Amit Bandyopadhyay, Susmita Bose
  • Publication number: 20140004200
    Abstract: A polymer composition that includes a hydrophilic amine-containing polymer, an optional secondary organic polymer, an optional foaming agent, and a bioactive agent distributed therein, wherein the bioactive agent is selected from the group consisting of a silver compound, a copper compound, a zinc compound, and combinations thereof.
    Type: Application
    Filed: September 5, 2013
    Publication date: January 2, 2014
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: SCOTT A. BURTON, PATRICK D. HYDE
  • Publication number: 20140004168
    Abstract: A biocidal glass composition for use in roofing applications can include glass doped with at least one biocidal agent that includes about 0.01 wt. % to about 50 wt. % of a total weight % of the biocidal glass composition. The biocidal glass composition can be included in a coating on a base particle of a roofing granule. Further included is a process of forming the roofing granule.
    Type: Application
    Filed: March 15, 2013
    Publication date: January 2, 2014
    Inventors: Pierre-Olivier Petit, Keith C. Hong, Gregory F. Jacobs, Kamila Plevacova
  • Publication number: 20140005616
    Abstract: Single layer and multi-layer anti-microbial wound care fabrics, gloves, sleeves, anklets, socks, finger cots, masks, and similar wound care articles are disclosed.
    Type: Application
    Filed: June 27, 2013
    Publication date: January 2, 2014
    Applicant: Ansell Limited
    Inventors: JEFFREY MORELAND, ROGER EUGENE HUCKFELDT, DION ROSS, ERIC THOMPSON, JAMIE ASHWORTH, MICHAEL ZEDALIS, ANTHONY B. LOPEZ
  • Patent number: 8617618
    Abstract: Disclosed are topical compositions containing the active ingredient magaldrate mixed with suitable vehicles and excipients.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: December 31, 2013
    Assignee: Difass International S.R.L.
    Inventor: Pier Luigi Guasti
  • Publication number: 20130344123
    Abstract: The disclosure relates to coatings that contain silver, either in the form of metallic silver, silver oxides, salts of silver, or combinations of these. The silver is present in a microparticulate or nanoparticulate form, which exerts antimicrobial activity when bacteria (e.g., in a body fluid) contact the coated surface. The coatings are applied through accumulation of silver-containing particles on the surface, such as by sputtering or electron beam vapor deposition. As a result, their thickness, particle size, and density can be controlled. Furthermore, the surface can also be coated with other substances, such as diamond-like carbon or alumina, either as a discrete layer or intermixed with the silver-containing particles.
    Type: Application
    Filed: March 4, 2013
    Publication date: December 26, 2013
    Applicant: Rowan University
    Inventors: Robert OSTRUM, Jeffrey HETTINGER, Robert KRCHNAVEK, Gregory A. CAPUTO
  • Publication number: 20130343997
    Abstract: Core-shell nanoparticles comprises a phosphorescent core and metal shell comprising at least two metals The phosphorescent core may comprise an up converting phosphor. The phosphorescent core may comprise a trivalent rare earth cation. The phosphorescent core further may comprise a monovalent alkali metal. The phosphorescent core may optionally comprises a second and also optionally a third trivalent rare earth cation.
    Type: Application
    Filed: December 16, 2011
    Publication date: December 26, 2013
    Inventors: Ian M. Kennedy, Sudheendra Lakshmana
  • Publication number: 20130344166
    Abstract: A topical mixture intended to reduce undesirable Iron levels in the cells to optimize Mitochondrial functioning. A method of reducing undesirable levels of Iron in the cells to optimize Mitochondrial functioning.
    Type: Application
    Filed: June 25, 2012
    Publication date: December 26, 2013
    Inventor: PIERRE ERNEST LOUBET
  • Publication number: 20130336899
    Abstract: The invention discloses compositions and formulations for the treatment of clean or infected wounds, some of the inventive formulations can be used to reduce or eliminate microbial contamination from surfaces such as skin, and inanimate objects such as countertops, cooking utensils, medical devices, cookware, food, grooming aids and agricultural biocides, and the like. Some of these compositions and formulations are well suited for use in wound dressings. Some of the formulation can kill and/or inhibit the growth of pathogenic bacteria, fungi, spores and viruses. The formulations comprise a compound such as an osmoticum in high enough concentration to create an osmotic gradient and at least one compound that acts to comprise the integrity of a microorganism's membrane or cell wall. These formulations may optimally include at least one agent that thickens the formulations. In some aspects the formulation is in the form of an emulsion.
    Type: Application
    Filed: October 11, 2011
    Publication date: December 19, 2013
    Applicant: Purdue Research Foundation
    Inventors: Jianming Li, Sean Connell
  • Publication number: 20130330417
    Abstract: Nanocellulose foams containing at least one active ingredient and methods of preparing such nanocellulose foams containing one or more active ingredients are provided herein. In some embodiments, a method for preparing nanocellulose foam containing active ingredients may include forming a liquid mixture of nanocellulose, wherein the nanocellulose is at least one of dispersed, suspended or gelled in the liquid mixture; drying the liquid mixture of nanocellulose to form a nanocellulose foam; and mixing at least one active ingredient into at least one of the liquid mixture of nanocellulose or the nanocellulose foam. In some embodiments, a nanocellulose structure may include a nanocellulose foam comprising at least one of a carboxylate group, a hydroxyl group, or a sulfate group bonded to an active ingredient. In some embodiments, the nanocellulose structures are enhanced or crosslinked with metal cations.
    Type: Application
    Filed: June 7, 2013
    Publication date: December 12, 2013
    Inventors: Hong Dong, James F. Snyder
  • Publication number: 20130330416
    Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.
    Type: Application
    Filed: June 8, 2012
    Publication date: December 12, 2013
    Inventor: Robert J. Greenwald
  • Publication number: 20130330418
    Abstract: An antimicrobial composition contains a soluble silver salt and an alkanolamine or aminoalcohol. The composition may additionally contain an amino acid or amino acid salt and surfactant. The composition has additional stability and activity compared to prior art silver complexes.
    Type: Application
    Filed: August 13, 2013
    Publication date: December 12, 2013
    Applicant: The Clorox Company
    Inventors: David R. SCHEUING, Erika SZEKERES, Steven BROMBERG
  • Publication number: 20130323183
    Abstract: The invention discloses pharmaceutical compositions in the form of a dusting powder or dry spray, possessing a high absorbent capacity, painkilling activity and wound-healing action, which compositions consist of croscarmellose sodium, a non-steroidal anti-inflammatory drug (NSAID) and hyaluronic acid, and optionally also contain other pharmacologically active substances and/or excipients. The compositions disclosed herein are suitable for use in the treatment of skin lesions wherein the presence of exudate limits wound healing and causes pain; they are therefore particularly suitable for chronic ulcerous skin lesions of various origins and burns.
    Type: Application
    Filed: February 13, 2012
    Publication date: December 5, 2013
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Andrea Pastorello, Devis Galesso, Fabio Bettella
  • Publication number: 20130315972
    Abstract: Compositions having antimicrobial activity contain particles comprising at least one inorganic copper salt; and at least one functionalizing agent in contact with the particles, the functionalizing agent stabilizing the particle in a carrier such that an antimicrobially effective amount of ions are released into the environment of a microbe. The average size of the particles ranges from about 1000 nm to about 3 nm. Preferred copper salts include copper iodide, copper bromide and copper chloride, most preferred being copper iodide. Preferred functionalizing agents comprise materials with a molecular weight of 60 or above, which include amino acids, other acidic materials, thiols, hydrophilic polymers, emulsions of hydrophobic polymers and surfactants. The functionalized particles are preferably made by a grinding process.
    Type: Application
    Filed: November 26, 2012
    Publication date: November 28, 2013
    Applicant: AGIENIC, INC.
    Inventors: Nicholas R. Krasnow, Lori L. Adams, John P. Cronin, Ryan J. Reeser, Anoop Agrawal, Donald R. Uhlmann
  • Publication number: 20130309318
    Abstract: A topical formulation for application to exposed body tissue, the formulation containing: (a) a silver oxide, and (b) at least one inorganic whitener; selected from the group of inorganic whiteners consisting of an inorganic magnesium compound and an inorganic calcium compound, said silver oxide and said inorganic whitener compound intimately dispersed within a carrier medium, and wherein a ratio of said inorganic whitener compound, to said silver oxide, is at least 0.2:1, by weight.
    Type: Application
    Filed: January 23, 2012
    Publication date: November 21, 2013
    Applicant: AIDANCE SKINCARE & TOPICAL SOLUTIONS LLC
    Inventors: Bharat Madhavan, Perry Antelman, Shalom Lampert
  • Publication number: 20130309288
    Abstract: Substrate with Antimicrobial Properties An antimicrobial substrate (glass, ceramic or metallic) coated on at least one of its surface with at least one mixed layer deposited by a sputtering under vacuum magnetically enhanced process is described. The layer comprising at least one antimicrobial agent mixed to binder material chosen amongst the metal oxides, oxynitrides, oxycarbides or nitrides. This substrate present antimicrobial properties, in particular bactericidal activity even when no thermal treatment has been applied. If a tempered and antimicrobial glass is required, the same co-sputtering process can be used, optionally an underlayer can be added. Antimicrobial properties are maintained even after a tempering process.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 21, 2013
    Applicant: AGC GLASS EUROPE
    Inventors: Georges PILLOY, Andre Hecq, Kadosa Hevesi, Nadia Jacobs
  • Publication number: 20130306090
    Abstract: An antimicrobial composition includes ABS resin; and Nano silver antimicrobial agent. The weight ratio between ABS resin and Nano silver anti-bacterial agent can be about 200:1. An antimicrobial artificial nail product includes a nail body that includes the antimicrobial composition. The nail body has a front side and a back side; and an adhesive layer may be applied on the back side of the nail body, which including a front side and a back side. A protective layer may be applied on the back side of the adhesive layer. The adhesive layer can be in the middle of the back side of the artificial nail body.
    Type: Application
    Filed: April 29, 2013
    Publication date: November 21, 2013
    Inventor: Zhenbiao Wang
  • Publication number: 20130302440
    Abstract: An antimicrobial structure surface therein wherein the structure surface includes an antimicrobial agent having a biocidal metal ion source and compound containing a hydantoin ring wherein the compound containing the hydantoin ring may or may not have antibacterial properties but the combination of the compound containing the hydantoin ring and the biocidal metal ion source when in the presence of a liquid coact to increase the level of available metal ions for killing microorganisms on the structure surface.
    Type: Application
    Filed: March 1, 2013
    Publication date: November 14, 2013
    Inventors: Joseph King, John Hill
  • Publication number: 20130295195
    Abstract: A method for increasing weight gain, water consumption, and rate of food consumption in poultry by administering an aqueous, acidic composition to the poultry drinking water is presented.
    Type: Application
    Filed: March 12, 2013
    Publication date: November 7, 2013
    Applicant: Contact Marketing Solutions Innovative Technologies
    Inventors: Jerry B. Creasey, Jason H. Creasey, David H. Creasey
  • Publication number: 20130295150
    Abstract: The invention features a galvanic particulate including a first conductive material and a second conductive material, wherein both the first conductive material and the second conductive material are exposed on the surface of the particulate, wherein the particle size of the particulate is from about 10 nanometers to about 100 micrometers, wherein the second conductive material comprises from about 0.01 percent to about 10 percent, by weight, of the total weight of the particulate, and wherein the difference of the standard potentials of the first conductive material and the second conductive material is at least about 0.2 V.
    Type: Application
    Filed: April 25, 2013
    Publication date: November 7, 2013
    Applicant: Johnson & Johnson Consumer Companies, Inc.
    Inventor: Johnson & Johnson Consumer Companies, Inc.
  • Publication number: 20130295184
    Abstract: Implantable medical devices having galvanic particulates are disclosed. The particulate may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The present invention further provides a combination of galvanic particulates with an aqueous gel, a method of making this combination, and a method of treatment using this combination. The devices and compositions may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, tissue regeneration promoting, and pain reduction or elimination.
    Type: Application
    Filed: July 9, 2013
    Publication date: November 7, 2013
    Inventors: Jennifer Hagyoung Kang Choi, Chunlin Yang, Ying Sun, Carrie H. Fang, James E. Hauschild, Abla A. Creasey
  • Patent number: 8568791
    Abstract: The present invention herein provides antibacterial zeolite particles whose ion-exchangeable ions have completely or partially been replaced with silver ions and zinc ions, wherein the ratio (A/B) of the silver ion concentration (A) to the zinc ion concentration (B) in the antibacterial zeolite particles increases in the direction along the depth of each zeolite particle. The antibacterial zeolite particles show excellent discoloration-resistant characteristics, while maintaining their excellent antibacterial activities. Accordingly, the antibacterial zeolite particles can suitably be applied to all sorts of products that are required to have antibacterial properties.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: October 29, 2013
    Assignee: Sinanen Zeomic Co., Ltd.
    Inventors: Yasuo Kurihara, Kumiko Miyake, Masashi Uchida
  • Publication number: 20130280303
    Abstract: A covering for delivering a therapeutic agent to a surgical site is provided. The covering may include a single or multi-compartment structure configured to at least partially retain the therapeutic agent until the covering is placed at a surgical site. Upon placement, the covering may facilitate transfer of the therapeutic agent to the surgical site. In some embodiments, the covering comprises an antimicrobial agent, a hemostatic agent, an anti-inflammatory agent, and/or a growth factor.
    Type: Application
    Filed: April 19, 2012
    Publication date: October 24, 2013
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Susan J. Drapeau, Guobao Wei
  • Publication number: 20130280345
    Abstract: The invention describes an antimicrobial agent for the biocidal finishing of polymers, especially foam materials, based on a fine-pored foamed and fine-grained ground silvered glass, which in addition to a silver fraction also contains a fraction of zinc oxide. In order to provide an economical antimicrobial agent with good biocidal effect it is proposed that zinc oxide powder is admixed to the fine-grained silvered glass.
    Type: Application
    Filed: August 30, 2012
    Publication date: October 24, 2013
    Applicant: WENATEX FORSCHUNG - ENTWICKLUNG - PRODUKTION GMBH
    Inventor: Karl Rametsteiner
  • Patent number: 8563020
    Abstract: Embodiments of the invention are directed to a composition having antimicrobial activity comprising particles comprising at least one inorganic copper salt; and at least one functionalizing agent in contact with the particles, the functionalizing agent stabilizing the particle in a carrier such that an antimicrobially effective amount of ions are released into the environment of a microbe. The average size of the particles ranges from about 1000 nm to about 4 nm. Preferred copper salts include copper iodide, copper bromide and copper chloride. Preferred functionalizing agents include amino acids, thiols, hydrophilic polymers emulsions of hydrophobic polymers and surfactants.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: October 22, 2013
    Assignee: Agienic, Inc.
    Inventors: Donald R. Uhlmann, Anoop Agrawal, Murat Akarsu, John P. Cronin
  • Publication number: 20130273174
    Abstract: The present invention relates to aqueous compositions of associative polyelectrolyte complexes (PECs), optionally containing surfactants, biocidal agents and/or oxidants, which can provide surface protection to treated articles including reduced soiling tendency, reduced cleaning effort and improved soil repellancy, as well as providing bacteriostatic properties to treated surfaces that thereby gain resistance to water, environmental exposure and microbial challenge. Treatment means and compositions are provided that employ associative polyelectrolyte complexes formed by combining a water soluble cationic first polyelectrolyte with a water soluble second polyelectrolyte bearing groups of opposite charge to the first polyelectrolyte under suitable mixing conditions where the one polyelectrolyte present in molar excess is added in the form of a first aqueous solution during a mixing step to a second aqueous solution comprising the oppositely charged polyelectrolyte present in molar deficiency.
    Type: Application
    Filed: May 3, 2013
    Publication date: October 17, 2013
    Inventors: David R. Scheuing, David J. Lestage, Carl W. Bennett, Mona M. Knock, Charles W. Scales, William L. Smith, Rui Zhang
  • Publication number: 20130266664
    Abstract: Electrospun scaffolds crosslinked with acrylates and methods of making the same are provided. Because the cross-linking linking is carried out under mild conditions, biologically active agents are incorporated into the scaffolds in a facile manner.
    Type: Application
    Filed: December 20, 2011
    Publication date: October 10, 2013
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Hu Yang, Gary L. Bowlin, Alpana Dongargaonkar
  • Publication number: 20130259916
    Abstract: Disclosed are surfactant compounds and compositions that are antimicrobial. Also provided are polymeric compositions incorporating the surfactant compounds. The polymeric compositions may be used to form antibacterial coatings on surfaces.
    Type: Application
    Filed: August 9, 2012
    Publication date: October 3, 2013
    Applicant: EASTERN MICHIGAN UNIVERSITY
    Inventor: John Texter
  • Patent number: 8535729
    Abstract: An antimicrobial composition contains a soluble silver salt and an alkanolamine or aminoalcohol. The composition may additionally contain an amino acid or amino acid salt and surfactant. The composition has additional stability and activity compared to prior art silver complexes.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: September 17, 2013
    Assignee: The Clorox Company
    Inventors: David R. Scheuing, Erika Szekeres, Steven Bromberg
  • Patent number: 8535728
    Abstract: Colorless composition comprising silver particles and water, wherein said particles comprise an interior of elemental silver and an exterior of ionic silver oxide, wherein the silver particles are present in the water at a level of about 5-40 ppm, and wherein the composition manifests significant antimicrobial properties. Methods of use of the composition are described. The composition can be incorporated into a hydrogel with essentially no loss of antimicrobial properties.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: September 17, 2013
    Assignee: American Silver, LLC
    Inventors: Robert J. Holladay, Herbert Christensen, William Moeller
  • Patent number: 8535710
    Abstract: A method for treating a wound, and a dressing for wound care management comprising a three-dimensional body of glass-based fibers comprising one or more glass-formers selected from the group consisting of P2O5, SiO2, and B2O3; at least about 25 wt % of the fibers have a diameter between about 200 nm and about 4000 nm, and a length:width aspect ratio of at least about 10. In another form, the glasses are in the form of particles in an ointment or cream applied to a wound. In yet other forms the glasses are employed as fibers formed into sutures for closing a wound, or as particles in a surgical glue for closing a wound.
    Type: Grant
    Filed: April 9, 2012
    Date of Patent: September 17, 2013
    Assignee: The Curators of the University of Missouri
    Inventors: Steven B. Jung, Delbert E. Day
  • Publication number: 20130236507
    Abstract: A method for treating a cancer is disclosed, which comprises: administering an effective amount of Fe-containing alloy particles to a subject in need, wherein a material of each Fe-containing alloy particle is an alloy comprising a first metal of Fe and a second metal.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 12, 2013
    Applicant: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Dar-Bin SHIEH, Li-Xing YANG, Ya-Na WU
  • Publication number: 20130238065
    Abstract: A phase change formulation includes a reversible phase change material and a thermal conductivity additive formulated for application to a user's epidermis.
    Type: Application
    Filed: March 6, 2012
    Publication date: September 12, 2013
    Applicant: EXERT CO.
    Inventor: Arvind M. Rao
  • Patent number: 8529935
    Abstract: The present invention relates to hydrogels endowed with antibacterial properties, to be used for injection in damaged bones or in the production of antibacterial coatings of prostheses for implant in the human or animal body, obtained by loading with antibacterial agents hydrogels formed by derivatives of hyaluronic acid; the invention also relates to a kit of parts for producing the antibacterial hydrogels.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: September 10, 2013
    Assignees: Mero S.R.L., Novagenit S.R.L.
    Inventors: Gaetano Giammona, Giovanna Pitarresi, Fabio Palumbo, Carlo Luca Romano, Enzo Meani, Edgardo Cremascoli
  • Patent number: 8529963
    Abstract: The present invention is directed to a method for preparing colloidal dispersions of precious metal nanoparticles selected from the group consisting of Pt, Au, Pd, Ag, Rh, Ru and mixtures or alloys thereof, and to a method for isolating such precious metal nanoparticles from these colloidal dispersions. The colloidal dispersions are prepared by reducing suitable precious metal precursor compounds in aqueous alkaline solutions at reaction temperatures between 40 and 70° C. and a pH?12.0 in the presence of polysaccharides with average molecular weights (Mw) in the range of 300,000 to 1,000,000. The precious metal nanoparticles are isolated after decomposing the polysaccharide by heating the colloidal dispersions to temperatures >80° C. The nanoparticles can be used for the manufacture of core/shell-type catalyst materials and for electronic, decorative and medical applications.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: September 10, 2013
    Assignee: Umicore AG & Co. KG
    Inventors: Dan V. Goia, Benjamin Morrow, Egon Matijevic, Krishna Balantrapu, Brendan P. Farrell
  • Publication number: 20130230603
    Abstract: Polyheterosiloxane compositions are disclosed containing at least 70% by weight of the following components: (A) a first metal (M1) selected from Ti, Zr, or Zn, (B) a second metal (M2), Zn, Cu, Bi, or Ag with the proviso that the second metal is not the same as the first metal, (C) siloxy units having the formula R?2SiO2/2 or R?SiO3/2 where R? is independently a hydrocarbon group or halogen substituted hydrocarbon group containing 1 to 18 carbon atoms. The disclosed compositions are useful to prepare antimicrobial materials.
    Type: Application
    Filed: January 5, 2012
    Publication date: September 5, 2013
    Applicant: Dow Corning Corporation
    Inventors: Nanguo Liu, Shawn Keith Mealey
  • Publication number: 20130230594
    Abstract: The present invention relates to compositions based on silver and hyaluronic acid and their use in the management of cutaneous lesions of various origin (acute and chronic wounds, ulcerations, burns, etc.) mainly when characterized by the presence of exudate and hence at high risk of infection.
    Type: Application
    Filed: November 4, 2011
    Publication date: September 5, 2013
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Giovanni Gennari, Giampaolo Menon, Susi Panfilo
  • Patent number: 8524797
    Abstract: A water-absorbent resin composition having an antimicrobial property, which suppresses the generation of dust of the antimicrobial agent. A water-absorbent resin composition comprising a water-absorbent resin and an antimicrobial agent comprising an inorganic compound carrying an antimicrobial metal, the water-absorbent resin composition being characterized in that the degree of generated dust of the water-absorbent resin composition is at most 100 CPM. The water-absorbent resin composition of the present invention can be suitably used as hygienic materials such as disposable diaper, sanitary napkin and incontinence pad; urine-absorbent materials for pets; materials for civil engineering and construction such as packing materials; drip absorbents; food freshness retaining materials such as cold-reserving agents; horticultural articles such as water-retaining materials for soils; and the like.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: September 3, 2013
    Assignee: Sumitomo Seika Chemicals Co., Ltd.
    Inventors: Takayasu Taniguchi, Tatsuya Oida, Yasuhiro Nawata
  • Publication number: 20130224274
    Abstract: The present invention relates to a medical product, comprising an antibacterial hard material coating, which is applied to a main body and which comprises biocide. Said hard material coating includes at least one inner layer and one outer layer, wherein the biocide concentration in the outer layer is substantially constant and greater than the biocide concentration in the inner layer and the biocide concentration in the inner layer is greater than or equal to 0.2 at %.
    Type: Application
    Filed: May 16, 2011
    Publication date: August 29, 2013
    Applicant: OERLIKON TRADING AG, TRUBBACH
    Inventors: Carmen Leonor Colmenares Mora, Arnd Mueller, Albert Peter Gerhard Janssen
  • Publication number: 20130224309
    Abstract: The present invention provides methods for making an antimicrobial medical device, preferably an antimicrobial ophthalmic device, more preferably an antimicrobial extended-wear contact lens, which contains silver nano-particles distributed uniformly therein. The antimicrobial medical device can exhibit antimicrobial activity over an extended period of time.
    Type: Application
    Filed: March 19, 2013
    Publication date: August 29, 2013
    Inventor: NOVARTIS AG